Potential causes of weight gain in type 1 diabetes mellitus

Diabetes, Obesity and Metabolism

Volumn 8, Issue 4, 2006, Pages 404-411

  Jacob, A N ^a   Salinas, K ^a   Adams Huet, B ^a   Raskin, Philip ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Ghrelin; Insulin therapy; Type1 diabetes; Weight gain

Indexed keywords

ADIPONECTIN; GHRELIN; HEMOGLOBIN A1C; INSULIN; LEPTIN; NITROGEN; UREA;

ADULT; APPETITE; ARTICLE; BODY FAT; BODY WEIGHT; BODY WEIGHT DISORDER; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES CONTROL; ENERGY EXPENDITURE; FEMALE; FOOD INTAKE; GLUCOSURIA; HEMOGLOBIN DETERMINATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LEAN BODY WEIGHT; MALE; OPEN STUDY; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; WEIGHT GAIN;

EID: 33748472265     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2005.00515.x     Document Type: Article

References (16)

1. The DCCT Research Group. Weight gain associated with intensive therapy in the DCCT. Diabetes Care 1988; 11: 567-573.
2. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure. JAMA 1998; 280: 140-146.
3. Purnell JQ, Dev RK, Steffes MW et al. Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the diabetes control and complications trial. Diabetes 2003; 52: 2623-2629.
4. Carlson MG, Campbell PJ. Intensive insulin therapy and weight gain in IDDM. Diabetes 1993; 42: 1700-1707.
5. Hall SE, Saunders J, Sonksen PH. Glucose and free fatty acid turnover in normal subject and in diabetic subject before and after insulin treatment. Diabetologia 1979; 16: 297-306.
6. Nair KS, Garrow JS, Ford C, Mahler RF, Halliday D. Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 1983; 25: 400-403.
7. Torbay N, Bracco EF, Geliebter A, Stweart IM, Hashim SA. Insulin increases body fat despite control of feed intake and physical activity. Am J Physiol 1985; 248: R120-R124.
8. Nair KS, Halliday D, Garrow JS. Increased energy expenditure in poorly controlled type 1 diabetic subjects. Diabetologia 1984; 27: 13-16.
9. Jackson AS, Pollock ML, Ward A. Generalized equations for predicting body density of women. Med Sci Sports Exerc 1980; 12: 175-182.
10. Jackson AS, Pollock ML. Generalized equations for predicting body density of men. Br J Nutr 1978; 40: 497-504.
11. Ainsworth BE, Haskell WL, Leon AS et al. Compendium of physical activities: An update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32: S498-S504.
12. Strowig SM, Avilés-Santa ML, Raskin P. Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes. Diabetes Care 2002; 25: 1691-1698.
13. Avilés-Santa L, Sinding J, Raskin P. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus: A randomized, double-blinded, placebo-controlled trial. Ann Intern Med 1999; 131: 182-188.
14. Wren AM, Seal LJ, Cohen MA et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992-5995.
15. O'Rahilly S, Farooqi S, Yeo GSH, Challis BG. Minireview: Human obesity -lessons from monogenic disorders. Endocrinology 2003; 144: 3757-3764.
16. Perseghin G, Lattuada G, Danna M et al. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 2003; 285: E1174-E1181.